Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been roughly five months since my previous Halozyme Therapeutics (NASDAQ: HALO ) article , where is discussed the company’s failed attempt to acquire Evotec ( EVO ) and the impact of Johnson & Johnson (He is the leader of the investing group Compo ...